Through its publications, INSS provides rigorous, forward‑looking research and analysis on critical national security issues that support the joint warfighter and inform Department of War decision‑makers.
July 23, 2019
Systems-based Approach to Biodefense Policy Analysis
In this article, co-authored by Dr. Diane DiEuliis, the authors describe a systems-based analysis of the US biosecurity and biodefense policy landscape to analyze functional relationships between policies. They identify two approaches in US policy for countering biological threats: prevention of theft, diversion, or deliberate malicious use of biological technologies, and development of capabilities and knowledge to assess, detect, monitor, respond to, and attribute biological threats.
June 25, 2018
Roadmap for Implementing Biosecurity and Biodefense Policy in the United States
This past year, Dr. Diane DiEuliis, in partnership with Gryphon Scientific and Parsons, undertook an ambitious, systems-based analysis of biosecurity and biodefense policy in the United States. Here you can find the full report, an executive summary of the report, and the resultant Roadmap for U.S biodefense policy.
Oct. 3, 2017
Options for Synthetic DNA Order Screening, Revisited
DNA synthesis is a valuable research tool in the design of new biological products for medicine and manufacturing, and the ability to chemically synthesize long tracts of DNA has allowed for the development of influenza vaccines and diagnostic tests.
Nov. 3, 2015
In Good Health? The Biological Weapons Convention and the “Medicalization” of Security
Since the 1990s, the group of stakeholders working to combat biological weapons (BW) proliferation has broadened to include new actors who have not traditionally focused on security issues, including organizations from the public health sector, researchers in the life sciences, and the biosafety community.
Feb. 1, 2001
Bioterrorism and Biocrimes: the Illicit Use of Biological Arms in the 20th century
This working paper is an updated study of research that began in 1998; it provides a descriptive analysis of the illicit use of biological agents by criminals and terrorists in the 20th century and draws on a series of specific case studies.